FDA Finally Revokes Emergency COVID-Flu Tests from Pfizer Era
Published Date: 1/2/2026
Notice
Summary
The FDA has officially ended the emergency use of two COVID-19 and flu tests made by Pfizer, effective October 22, 2025. This change affects anyone using these specific tests, as they’re no longer authorized for emergency use. No extra costs or deadlines for the public, but labs and providers should switch to other approved tests.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Pfizer Lucira Tests EUA Revoked
The FDA revoked the Emergency Use Authorizations (EUAs) for two tests: the Lucira by Pfizer COVID-19 & Flu Test and the Lucira by Pfizer COVID-19 & Flu Home Test. The revocations were effective October 22, 2025; Pfizer requested the revocations on October 10, 2025 and told FDA there were no viable test reagents remaining in the United States.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in